| 2024 | | Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis | 예영민 |
| 2024 | | Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Cannabinoid receptor 2 as a regulator of inflammation induced oleoylethanolamide in eosinophilic asthma | 박해심, 신유섭, 예영민 |
| 2024 | | Safety, Tolerability, Pharmacokinetics, and pharmacodynamics of YH35324, a novel Long-Acting High-Affinity IgETrap-Fc protein in subjects with Atopy: Results from the First-in-Human study | 박해심, 예영민 |
| 2024 | | Diagnostic biomarkers for chronic rhinosinusitis in adult asthmatics in real-world practice | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2024 | | Evaluation of the Regulatory Required Post-Authorization Safety Study for Propacetamol: Nested Case-Control and Case-Time-Control Studies | 예영민 |
| 2024 | | CRUSE®-An innovative mobile application for patient monitoring and management in chronic spontaneous urticaria | 예영민 |
| 2024 | | Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials | 예영민 |
| 2023 | | Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor | 강호철, 박해심, 신민경, 예영민, 조중현, 최보윤 |
| 2023 | | Nasal Transcriptome and Epigenome Analysis Identifies the Pathogenic Features of Aspirin-Exacerbated Respiratory Disease | 박해심, 예영민 |
| 2023 | | Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study | 예영민 |
| 2023 | | Urticaria exacerbations and adverse reactions in patients with chronic urticaria receiving COVID-19 vaccination: Results of the UCARE COVAC-CU study | 예영민, 이영수 |
| 2023 | | Treatment with biological products for chronic urticaria | 예영민 |
| 2023 | | Effects of COVID-19 and Influenza Vaccination on Rheumatic Diseases: Results From a Survey of Patient-Reported Outcomes After Vaccination | 김지원, 김현아, 서창희, 예영민, 정주양 |
| 2023 | | Efficacy of Second-Line Treatments in Chronic Urticaria Refractory to Standard Dose Antihistamines | 박해심, 신유섭, 예영민 |
| 2023 | | Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice | 김승현, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2023 | | Real-World Disease Burden of Chronic Urticaria and Vaccine Hesitancy | 예영민 |
| 2023 | | Association of eosinophil-derived neurotoxin levels with asthma control status in patients with aspirin-exacerbated respiratory disease | 박해심, 예영민 |
| 2023 | | Clinical aspects of severe cutaneous adverse reactions caused by beta-lactam antibiotics: A study from the Korea SCAR registry | 예영민 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
| 2022 | | A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization | 예영민 |
| 2022 | | Detection of serum IgG autoantibodies to FcεRIα by ELISA in patients with chronic spontaneous urticaria | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2022 | | Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU) | 박해심, 예영민, 유민숙, 이영수, 장재혁 |
| 2021 | | Cefaclor-induced hypersensitivity: Differences in the incidence of anaphylaxis relative to other 2nd and 3rd generation cephalosporins | 예영민, 이영수, 장재혁 |
| 2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria | 박해심, 예영민 |
| 2021 | | Oleoylethanolamide induces eosinophilic airway inflammation in bronchial asthma | 박해심, 신유섭, 예영민, 최영우 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | A Nationwide Study of Severe Cutaneous Adverse Reactions Based on the Multicenter Registry in Korea | 예영민 |
| 2021 | | Erratum: Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Establishment of reference intervals of serum immunoglobulins in healthy korean adults | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | COVID-19 vaccine-associated anaphylaxis and allergic reactions: Consensus statements of the KAAACI urticaria/angioedema/anaphylaxis working group | 박해심, 예영민, 이수영 |
| 2021 | | Screening for autoimmune comorbidities in patients with chronic spontaneous urticaria: Which tests to whom | 예영민 |
| 2021 | | Elevated MRGPRX2 levels related to disease severity in patients with chronic spontaneous urticaria | 예영민 |
| 2021 | | Risk factors predicting Severe Asthma exacerbations in adult asthmatics: A real-world clinical evidence | 박해심, 신유섭, 예영민 |
| 2021 | | Clustering the clinical course of chronic urticaria using a longitudinal database: Effects on urticaria remission | 남동호, 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | A prospective study to compare clinical outcomes of allergic rhinitis between older and younger adults: A potential effect of depression in older patients | 박해심, 신유섭, 예영민, 이영수 |
| 2021 | | Changes in type 2 biomarkers after anti-il5 treatment in patients with severe eosinophilic asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Severe cutaneous adverse reactions to anti-tuberculosis drugs in korean patients | 예영민 |
| 2021 | | Distribution and quality of life in patients with primary immunodeficiency diseases in a cohort of Korean adults | 박해심, 예영민 |
| 2021 | | Clinical characteristics and risk factors for cefaclor-induced immediate hypersensitivity: a retrospective observation at two university hospitals in Korea | 예영민, 우성대, 이영수 |
| 2020 | | Causes of food allergy according to age and severity: A recent 10-year retrospective study from a single tertiary hospital | 남동호, 박해심, 신유섭, 예영민, 이수영, 정경욱 |
| 2020 | | Increasing Prevalence and Mortality of Asthma With Age in Korea, 2002-2015: A Nationwide, Population-Based Study | 박해심, 예영민 |
| 2020 | | Efficacy and Safety of a Pressurized Metered-Dose Inhaler in Older Asthmatics: Comparison to a Dry Powder Inhaler in a 12-Week Randomized Trial | 박주헌, 박해심, 신유섭, 예영민, 우성대, 이영수 |
| 2020 | | Health-Related Utility of EQ-5D in Korean Adults With Chronic Urticaria: Mapping From Urticaria Outcome Measures | 박해심, 신유섭, 예영민 |
| 2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
| 2020 | | A Prospective Observation of Psychological Distress in Patients With Anaphylaxis | 예영민, 이영수, 장형윤 |
| 2020 | | Efficacy, Safety, and Immunomodulatory Effect of the Intramuscular Administration of Autologous Total Immunoglobulin G for Atopic Dermatitis: A Randomized Clinical Trial | 남동호, 박해심, 신유섭, 예영민 |
| 2020 | | Omalizumab Treatment in Patients With Cholinergic Urticaria: A Real-World Retrospective Study in Korea | 박해심, 신유섭, 예영민 |
| 2020 | | The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria | 예영민 |
| 2020 | | The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 1. Definition, Methodology and First-line Management | 예영민 |
